Surgical management of left-divisional intrahepatic portosystemic shunts: outcome after partial ligation of, or ameroid ring constrictor placement on, the left hepatic vein in twenty-eight dogs (1995-2005)

OBJECTIVES: To evaluate outcome in dogs with left divisional intrahepatic portosystemic shunts (PSS) treated by partial ligation (PL) or ameroid ring constrictor (ARC) placement on the left hepatic vein. DESIGN: Retrospective study. ANIMALS: Dogs (n=28) with left divisional intrahepatic PSS. METHODS: Retrieved data from medical records of dogs with left divisional intrahepatic PSS that had PL (n=17) or ARC (n=11) were signalment, history, clinical signs, preoperative blood work, portal pressure measurements, ARC size, complications and postoperative technetium scintigraphy. Outcome assessed by owner interview 6 months-10 years after surgery was classified as excellent, good or poor. Differences were tested by exact chi2 test. RESULTS: Major complications occurred in 3 dogs: coagulopathy (1 PL dog died), ascites (1 PL dog survived) and seizures (1 ARC dog died). Eight PL dogs had technetium portal scintigraphy; 1 dog was negative and 7 dogs positive for persistent shunting. Seven ARC dogs had scintigraphy; 4 dogs were negative and 3 positive for persistent shunting. In PL dogs, long-term clinical outcome was excellent (92%) or good (8%) whereas, in ARC dogs it was excellent (20%), good (50%) or poor (30%). This outcome difference between treatment groups was significant (P=.0012). CONCLUSION: Dogs treated by PL had significantly better long-term outcome compared with ARC treated dogs. CLINICAL RELEVANCE: Based on these data, ARC placement on the left hepatic vein in dogs with left-divisional intrahepatic PSS cannot be recommended.     

HIGH DOSE NARCOTIC ANAESTHESIA USING SUFENTANIL IN SWINE AND DOGS

Abstract: Protocols for utilizing intravenous infusions of sufentanil were developed for experimental cardiac surgery in swine and dogs. After initial experiences with fentanyl, sufentanil was selected for these procedures due to its increased potency and shorter half life thus requiring a smaller volume for infusion and more control. In dogs with experimental mitral valve regurgitation, an initial bolus of sufentanil 3 γg/kg IV was followed by a continuous IV infusion at a rate of 9–13 γg/kg/hr. Swine used in experiments involving cardiac conduction system ablation received ketamine 33 mg/kg IM and acepromazine 1.1 mg/kg IM as a preanesthetic combination. Following the preanesthetic, an initial infusion of sufentanil 15 γg/kg/hr was started and a loading dose of sufentanil 7 γg/kg IV was administered as a bolus for induction. They were then maintained by a continuous IV infusion at a rate of 15–30 γg/kg/hr. Dogs but not pigs required periodic supplementation of anaesthesia with isoflurane and/or nitrous oxide during portions of the experimental protocol. No anaesthetic related deaths have occurred in either species using these anaesthetic protocols for cardiac procedures.     

Feeding practices of pet dogs and determination of an allometric feeding equation

This study indicates that measuring caloric intake data of dogs in homes is achievable and can provide a practical and appropriate methodology for determining energy needs. This knowledge can be helpful in developing appropriate guidelines for pet food labels.     

Far red bioluminescence from two deep-sea fishes

Spectral measurements of red bioluminescence were obtained from the deep-sea stomiatoid fishes Aristostomias scintillans (Gilbert) and Malacosteus niger (Ayres). Red luminescence from suborbital light organs extends to the near infrared, with peak emission at approximately 705 nanometers in the far red. These fishes also have postorbital light organs that emit blue luminescence with maxima between 470 and 480 nanometers. The red bioluminescence may be due to an energy transfer system and wavelength-selective filtering.